Bookmark and Share

Compound Summary for: CID 9574101

ximelagatran

Also known as: Exanta, Exarta, H 376-95, Exanta (TN), H 376/95, H 37695, Ximelagatran [USAN:INN], Ximelagatran (JAN/USAN/INN)
Molecular Formula: C24H35N5O5   Molecular Weight: 473.5652   InChIKey: ZXIBCJHYVWYIKI-PZJWPPBQSA-N
Ximelagatran (Exanta® or Exarta®, H 376/95) is an anticoagulant that has been investigated extensively as a replacement for warfarin that would overcome the problematic dietary, drug interaction, and monitoring issues associated with warfarin therapy. In 2006, its manufacturer AstraZeneca announced that it would not attempt to market ximelagatran after reports of hepatotoxicity (liver damage) during trials, and to discontinue its distribution in countries where the drug had been approved.   From: DrugBank
Show subcontent titlesTable of Contents
Identification
Related Records
show all 3 sub-sections (Related Compounds with Annotation, Related Compounds, Related Substances)
Pharmacology
Literature
Patents
Biomolecular Interactions and Pathways
Biological Test Results
Classification
Chemical and Physical Properties
_ _